A multicenter retrospective analysis of patients with nasopharyngeal carcinoma treated in IMRT era from a nonendemic population: Turkish Society for Radiation Oncology Head and Neck Cancer Group Study (TROD 01-001)
dc.authorid | 0000-0002-1412-1933 | en_US |
dc.authorid | 0000-0002-3315-3893 | en_US |
dc.authorid | 0000-0001-6029-1995 | en_US |
dc.contributor.author | Yıldırım, Halil Cumhur | |
dc.contributor.author | Kupik, Gülnihan Eren | |
dc.contributor.author | Mustafayev, Teuta Zoto | |
dc.contributor.author | Berber, Tanju | |
dc.contributor.author | Yavuz, Berrin | |
dc.contributor.author | Çetinayak, Oğuz | |
dc.contributor.author | Teke, Fatma | |
dc.date.accessioned | 2023-10-17T11:08:23Z | |
dc.date.available | 2023-10-17T11:08:23Z | |
dc.date.issued | 2023 | en_US |
dc.department | Dicle Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıklar Ana Bilim Dalı | en_US |
dc.description.abstract | Background: We aimed to evaluate patients with nasopharyngeal carcinoma (NPC) in a nonendemic population. Methods: In a national, retrospective, multicenteric study, 563 patients treated with intensity modulated radiotherapy at 22 centers between 2015 and 2020 were analyzed. Results: Median age was 48 (9–83), age distribution was bimodal, 74.1% were male, and 78.7% were stage III-IVA. Keratinizing and undifferentiated carcinoma rates were 3.9% and 81.2%. Patients were treated with concomitant chemoradiotherapy (48.9%), or radiotherapy combined with induction chemotherapy (25%) or adjuvant chemotherapy (19.5%). After 34 (6–78) months follow-up, 8.2% locoregional and 8% distant relapse were observed. Three-year overall survival was 89.5% and was lower in patients with age ≥50, male sex, keratinizing histology, T4, N3 and advanced stage (III-IVA). Conclusions: Patients with NPC in Turkey have mixed clinical features of both east and west. Survival outcomes are comparable to other reported series; however, the rate of distant metastases seems to be lower. | en_US |
dc.description.sponsorship | University Grants Commission, India: 8- 4(57)/2015(MRP/NRCB | en_US |
dc.identifier.citation | Yıldırım, H. C., Kupik, G. E., Mustafayev, T. Z., Berber, T., Yavuz, B., Çetinayak, O. ve diğerleri. (2023). A multicenter retrospective analysis of patients with nasopharyngeal carcinoma treated in IMRT era from a nonendemic population: Turkish Society for Radiation Oncology Head and Neck Cancer Group Study (TROD 01-001). Head and Neck, 45(5), 1194-1205. | en_US |
dc.identifier.doi | 10.1002/hed.27333 | |
dc.identifier.endpage | 1205 | en_US |
dc.identifier.issn | 1043-3074 | |
dc.identifier.issue | 5 | en_US |
dc.identifier.pmid | 36854873 | |
dc.identifier.scopus | 2-s2.0-85149269238 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 1194 | en_US |
dc.identifier.uri | https://onlinelibrary.wiley.com/doi/10.1002/hed.27333 | |
dc.identifier.uri | https://hdl.handle.net/11468/12825 | |
dc.identifier.volume | 45 | en_US |
dc.identifier.wos | WOS:000940768500001 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.institutionauthor | Teke, Fatma | |
dc.language.iso | en | en_US |
dc.publisher | John Wiley and Sons Inc. | en_US |
dc.relation.ispartof | Head and Neck | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Chemoradiotherapy | en_US |
dc.subject | EBV-DNA | en_US |
dc.subject | Intensity-modulated radiotherapy | en_US |
dc.subject | Nasopharyngeal carcinoma | en_US |
dc.subject | Nonendemic | en_US |
dc.title | A multicenter retrospective analysis of patients with nasopharyngeal carcinoma treated in IMRT era from a nonendemic population: Turkish Society for Radiation Oncology Head and Neck Cancer Group Study (TROD 01-001) | en_US |
dc.title | A multicenter retrospective analysis of patients with nasopharyngeal carcinoma treated in IMRT era from a nonendemic population: Turkish Society for Radiation Oncology Head and Neck Cancer Group Study (TROD 01-001) | |
dc.type | Article | en_US |